Fundz

ALP Bio raises €161K from Venture Kick to enhance the safety of biologic medicines, aiming for better immune risk assessment.

PRIVATEJul 03, 2026

Amount Raised

€161,000

Round Type

Pre-Seed

SwitzerlandBiotechnologyArtificial Intelligence

Investors

Venture Kick

Description

ALP Bio, a Swiss biotech startup, has secured €161,000 from Venture Kick for the commercial development of its immune risk assessment platform. The funding will support the company's first pilot projects with pharmaceutical partners. By combining AI with human immune models, ALP Bio aims to improve drug safety and design. This strategic funding will facilitate validation of its technology in real-world settings.

Quick answer

ALP Bio raised €161,000 in a Pre-Seed round, dated July 3, 2026. Investors: Venture Kick. ALP Bio is based in Switzerland.

How much did ALP Bio raise?
ALP Bio raised €161,000 in a Pre-Seed round on July 3, 2026.
Who invested in ALP Bio?
Venture Kick is named as investors in this round.
What does ALP Bio do?
ALP Bio is a Swiss biotech startup that develops a platform to help drug developers identify immune-related risks earlier in the development process.
Where is ALP Bio based and how big is it?
ALP Bio is based in Switzerland. Fundz records about 5 employees.
Who are the decision-makers at ALP Bio?
Fundz holds 1 contact at ALP Bio, including the Co-Founder and Chief Scientist. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as ALP Bio that raised within 45 days of this round, from Fundz verified event records.

  • Phil Rivers Technology raised $30M (Series A) on August 13, 2026.
  • Westlake Robotics raised $16M (Series A) on August 13, 2026.
  • N2TP raised an undisclosed amount (Seed) on August 13, 2026.
  • Beyang Therapeutics Ltd raised $30M (Series A) on August 12, 2026.
  • Innocens raised $1.7M (Pre-Seed) on August 11, 2026.
  • Sonablate raised $200M on August 10, 2026.

Who to call at ALP Bio, and when

A new round usually means ALP Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ALP Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ALP Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ALP Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ALP Bio

Location

Switzerland

About

ALP Bio is a Swiss biotech startup that develops a platform to help drug developers identify immune-related risks earlier in the development process. By combining human immune tissue models with artificial intelligence, it aims to improve the safety and success rate of next-generation biologic medicines. The company addresses challenges in predicting immune responses to biologic drugs to increase the likelihood of successful clinical outcomes. Founded by experts in immunology, AI, protein engineering, and business development, ALP Bio focuses on validating its technology through pilot projects with pharmaceutical partners.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ALP Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLucas P., Co-Founder and Chief Scientist hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ALP Bio's next move

See what Strategic adds

ALP Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.